Kristopher Sturgis is a freelance contributor to MD+DI.
Using the latest in virtual and augmented reality technology, an award winning medical technology company is creating lifelike video game simulations to help train physicians and improve diagnosis and treatment methods.
The company has launched the ‘Relay robot,’ a new autonomous service robot designed to optimize labor productivity in hospital lab environments.
A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.
A new competition that aims to develop innovative and sustainable ideas for injection medicine has awarded a development contract to the winner for a novel documentation process for drug administration.
Thanks to a new validation and part process, molders can now replicate transferable plastic conditions that can save millions of dollars a year and reduce machine downtime.
Even though plastic is easy to use, cost effective, and well established, medtech engineers can run into challenges.
Bebop Sensors is developing a new line of sensor technologies aimed at powering new wearable devices and smart fabrics.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
An industry expert shares a few tips on how to be proactive when it comes to evaluating and improving product performance.
An expert in quality management discusses the importance of a quality design plan and how to map out a path to success for device makers.
BAROnova has submitted a premarket approval application to FDA for an implantable device designed to treat obesity.
A new diagnostic system with digital imaging capabilities aims to enhance lab capabilities across the globe through multi-test processing, dry slide technology, and a full testing environment for accurate testing in a waterless environment.
The new implant was specifically designed to simplify key stages of spinal fusion surgery to help restore spinal disc height between two vertebrae.
FibreTuff plans to develop cellulose-based biomaterials that can be used to 3D print Class I and II medical devices for spine, trauma, and sports medicine.